todays heightened threat environment increased need safe effective means protect special service groups general population large health hazards unintended ionizing radiation exposures unfulfilled dream globally effective pharmacologic easily taken orally undue effects prior suspected impending event ideal radioprotective agent identified let fully developed approved human use argue fact problematic needs corrected ultimate solution difficult problem question representative species aminothiol family amifostine medimmune gaithersburg maryland proven potent cytoprotectants normal tissues subjected irradiation radiomimetic chemicals amifostine currently used clinically drug toxicity limited times protection unfavorable routes administration serve limit drugs utility nonclinical settings range research development strategies employed currently hunt new safe effective radioprotectants include NUMBER large scale screening new chemical classes natural products NUMBER older protectants proven efficacies unwanted toxicities NUMBER using nutraceuticals moderately protective essentially nontoxic NUMBER using low dose combinations potentially toxic efficacious agents protect different routes foster radioprotective synergy NUMBER accepting lower level drug efficacy lieu reduced toxicity banking premise protection afforded leveraged therapies difficult predict strategies ultimately prove successful certain probability useful protectant fielded increased significantly resurgence radiation protection increased resources expended federal agencies food drug administrations willingness innovate relative new approval guidance high risk post exposure nuclear biological chemical nuclear radiological restructuring reformulating